PROPOXYPHENE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Propoxyphene Hydrochloride, and what generic alternatives are available?
Propoxyphene Hydrochloride is a drug marketed by Alra, Impax Labs, Ivax Sub Teva Pharms, Mutual Pharm, Mylan, Nexgen Pharma Inc, Par Pharm, Purepac Pharm, Pvt Form, Roxane, Sandoz, Teva, Valeant Pharm Intl, Vintage Pharms, Watson Labs, West Ward, Whiteworth Town Plsn, and Warner Chilcott. and is included in thirty-two NDAs.
The generic ingredient in PROPOXYPHENE HYDROCHLORIDE is aspirin; caffeine; propoxyphene hydrochloride. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; caffeine; propoxyphene hydrochloride profile page.
Summary for PROPOXYPHENE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 18 |
NDAs: | 32 |
Raw Ingredient (Bulk) Api Vendors: | 24 |
Clinical Trials: | 8 |
Patent Applications: | 2,149 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROPOXYPHENE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for PROPOXYPHENE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mansoura University | Phase 1/Phase 2 |
Federal University of São Paulo | Phase 4 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |